Form 4: Anixa Biosciences Director Reports Stock Transaction
Insider Transaction (Form 4)
Arnold M Baskies, a Director of Anixa Biosciences Inc, reported multiple transactions in common stock on July 27, 2026.
Summary
- Option exercise/conversion: acquired 6,000 Common Stock at $3.13 ($18,780) on July 27, 2026; holds 141,000 after (Direct).
- Tax/exercise-price withholding: disposed of 5,428 Common Stock at $3.46 ($18,781) on July 27, 2026; holds 135,572 after (Direct).
- Option exercise/conversion: disposed of 6,000 Employee Stock Option (Right to Buy) on July 27, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Arnold M Baskies — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Option exercise/conversion | Common Stock | 6,000 | $3 | $18.8K | 141,000 |
| 2026-07-27 | Tax/exercise-price withholding | Common Stock | 5,428 | $3 | $18.8K | 135,572 |
| 2026-07-27 | Option exercise/conversion | Employee Stock Option (Right to Buy) | 6,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Option exercise/conversion (6,000 shares) |
| 2026-07-27 | Tax/exercise-price withholding (5,428 shares) |
| 2026-07-27 | Option exercise/conversion (6,000 shares) |
Keywords
insider transaction, Form 4, ANIX, Anixa Biosciences Inc, neutral, Arnold M Baskies
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.